Page 4 - MemoriaEHD-Eng

tORGANIZATION

uThank you so much for following the scientific activity of the Networked Biomedi-

cal Research Center in Hepatic and Digestive Diseases (CIBERehd).

CIBERehd is a public consortium the aim of which is to promote high level trans-
lational research through the interaction of the best Spanish groups. CIBERehd pro-

vides its member groups with funds to finance research and support staff, collaborative
projects, common technological platforms, scientific-technical infrastructures and the

development of training activities. Established on November 29th, 2006, in 2013 it is

made up by 51 groups from 30 centres distributed in 9 regions.

Our mission is:

a) Execution of joint programmes of research, development and innovation in di-
gestive and liver diseases promoting interaction and synergies among the best
Letter from
Spanish groups..
the Scientific
b) Contributing to the resolution of health care problems related to the above men-
Director
tioned areas.

c) Promoting the transfer of the results of the research processes toward clinical
applications and to society, especially in the biotechnological and pharmaceutical

industry.

d) Promoting the participation in activities of priority research in the national sphere

and in projects included in the European Framework Programmes of R+D+I.

e) Promoting the diffusion of its activities and the training of competitive research-
ers in the field of digestive and liver diseases.

CIBERehd is directed by the Scientific Director, appointed by the ISCIII , who as-
sumes the responsibility of all CIBERehd actions with the assistance of the Steering

Committee comprising the Manager, the Training Coordinator and the Coordinators of
Research Programmes and Technological Platforms. He establishes the multiannual

action plan and its budget. CIBERehd funding mostly comes (80%) from ISCIII that

is basically used to cover salaries of researchers and support staff, to buy scientific-
technical infrastructure and, to a lesser extent, to train research staff and to cover

management and current expenses. The consorted institutions contribute with their fa-

cilities, services, and part of their staff (their staff researchers adhered to CIBERehd).
Likewise, CIBERehd self-finances more than 10% of its budget.

Research Programmes

13
• 1. Portal hypertension 20
T
• 2. Hepatitis R
PO
• 3. Choleastasis and metabolic disorders E
L R
• 4. Immunology and liver transplantation A
NU
• N
5. Liver and gastrointestinal oncology A
/
• 6. Gastrointestinal inflammation and motility.
HD
E
ER
IB
Technological Platforms include a Biobank, a Transcriptomic, Proteomic and Metabo- C
lomic Platform, a Pyrosequency Platform and a Bioinformatic Platform.
4